Remeditex Ventures
Overview
Remeditex Ventures is a venture capital firm based in Dallas, Texas, specializing in biotechnology investments. The firm focuses on high-quality, innovative, early-stage projects that demonstrate strong commercialization potential. By partnering with leading biomedical research institutions, Remeditex Ventures aims to translate promising scientific discoveries into marketable solutions, thereby enhancing health and well-being while fostering a robust biomedical industry in Texas. The firm's investment strategy encompasses both early and late-stage ventures, with a particular emphasis on biotechnology, health care, financial services, and science and engineering sectors. Remeditex Ventures has a history of significant investments, including a $55 million funding round for Bellicum Pharmaceuticals in 2014 and a $50 million investment in Menlo Therapeutics in 2017. These investments reflect the firm's commitment to supporting companies that are at the forefront of medical innovation. Through careful analysis and calculated risks, Remeditex Ventures provides the business and scientific discipline necessary to establish the commercial viability of research, making it attractive to traditional investors. The firm's goal is to bridge the gap between scientific discovery and market application, ensuring that groundbreaking research reaches the marketplace to improve health outcomes and contribute to the growth of the biomedical industry in Texas.
Investment Focus
- High-quality, innovative, early-stage biotechnology projects with strong commercialization potential
Portfolio Companies
Get the full list of 54,000+ investors
Remeditex Ventures and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Remeditex Ventures
What sectors does Remeditex Ventures invest in?
Remeditex Ventures invests in Financial Services, Health Care, Biotechnology and Science and Engineering, and is based in Dallas, United States. Remeditex Ventures is listed as a venture capital in the ConnectSafely investor database.
What stage does Remeditex Ventures invest at?
Remeditex Ventures backs companies at Early Stage and Late Stage, writing cheques of 20M - 55M.
Which regions does Remeditex Ventures invest in?
Remeditex Ventures invests across United States.
What companies has Remeditex Ventures invested in?
Remeditex Ventures's portfolio includes Bellicum Pharmaceuticals, Menlo Therapeutics, MiRagen Therapeutics, Navitor Pharmaceuticals, Quartet Medicine, Rodin Therapeutics, Tigercat Pharma and VuCOMP.
How do I contact Remeditex Ventures?
Remeditex Ventures's contact details — including phone — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
